Cargando…

Large Cell Change in a Small Liver: A Histological Clue to Short Telomere Syndromes?

Detalles Bibliográficos
Autores principales:	Johnson, Steven M., McGinty, Katrina A., Hayashi, Paul H., Sasatomi, Eizaburo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Clinical Observations In Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839464/ https://www.ncbi.nlm.nih.gov/pubmed/32294263 http://dx.doi.org/10.1002/hep.31272

Ejemplares similares

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease
por: Nascimbeni, Fabio, et al.
Publicado: (2016)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

Efficacy and Safety of 3‐Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases
por: Arase, Yoshitaka, et al.
Publicado: (2019)

Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
por: Kanwar, Pushpjeet, et al.
Publicado: (2016)

Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease
por: Wood, Kayleigh L, et al.
Publicado: (2015)

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
por: Duseja, Ajay, et al.
Publicado: (2019)

Effect of Plasmapheresis on Cholestatic Pruritus and Autotaxin Activity During Pregnancy
por: Heerkens, Marieke, et al.
Publicado: (2019)

Drug-Induced Liver Injury: Pattern Recognition and Future Directions
por: Haque, Tanvir, et al.
Publicado: (2016)

Raised Serum Ferritin Concentration in Hereditary Hyperferritinemia Cataract Syndrome Is Not a Marker for Iron Overload
por: Yin, Dan, et al.
Publicado: (2014)

Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis
por: Tucci, Francesca, et al.
Publicado: (2018)

Clinical Remission of Delta‐Aminolevulinic Acid Dehydratase Deficiency Through Suppression of Erythroid Heme Synthesis
por: Neeleman, Rochus A., et al.
Publicado: (2019)

Emergence of Oncogenic‐Enhancing Hepatitis B Virus X Gene Mutants in Patients Receiving Suboptimal Entecavir Treatment
por: Lin, Chih‐Lang, et al.
Publicado: (2019)

Loss of organic anion transporting polypeptide 1B3 function causes marked delay in indocyanine green clearance without any clinical symptoms
por: Kagawa, Tatehiro, et al.
Publicado: (2017)

Phenotype or Genotype: Decision‐Making Dilemmas in Hepatocellular Adenoma
por: Klompenhouwer, Anne J., et al.
Publicado: (2019)

Highly Elevated Plasma γ‐Glutamyltransferase Elevations: A Trait Caused by γ‐Glutamyltransferase 1 Transmembrane Mutations
por: De Grandi, Alessandro, et al.
Publicado: (2019)

Preliminary Evidence for Hepatitis Delta Virus Exposure in Patients Who Are Apparently Not Infected With Hepatitis B Virus
por: Chemin, Isabelle, et al.
Publicado: (2021)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Suppression of Noncoding RNAs as Shared Early Genetic Events in Multistep Hepatocarcinogenesis
por: Suda, Takeshi, et al.
Publicado: (2021)

Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis
por: Caporali, Cristian, et al.
Publicado: (2021)

Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis
por: Stevenson, Heather L., et al.
Publicado: (2017)

Dermoscopic clues to diagnose acantholytic dyskeratosis
por: Specchio, Francesca, et al.
Publicado: (2015)

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease
por: Hardy, Timothy, et al.
Publicado: (2017)

Dysregulated activation of fetal liver programme in acute liver failure
por: Hyun, Jeongeun, et al.
Publicado: (2019)

Uncovering undiagnosed liver disease: prevalence and opportunity for intervention in a population attending colonoscopy
por: Koo, Sara, et al.
Publicado: (2021)

COVID-19 and liver cancer: lost patients and larger tumours
por: Geh, Daniel, et al.
Publicado: (2022)

Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells
por: Dai, Zhen, et al.
Publicado: (2020)

Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
por: Zhang, Xiang, et al.
Publicado: (2021)

Public awareness and knowledge of liver health and diseases in Singapore
por: Tan, Chee‐Kiat, et al.
Publicado: (2021)

TGF-β2 silencing to target biliary-derived liver diseases
por: Dropmann, Anne, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease burden: Australia, 2019–2030
por: Adams, Leon A, et al.
Publicado: (2020)

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
por: Hallsworth, Kate, et al.
Publicado: (2011)

Liver steatosis and metabolic dysfunction-associated fatty liver disease among HIV-positive and negative adults in urban Zambia
por: Chihota, Belinda Varaidzo, et al.
Publicado: (2022)

Mechanisms of liver disease in patients infected with HIV
por: Kaspar, Matthew B, et al.
Publicado: (2017)

Changing trends of hospitalisation of liver cirrhosis in Beijing, China
por: Bao, Xiao-Yuan, et al.
Publicado: (2015)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Loss of hepatic Mboat7 leads to liver fibrosis
por: Thangapandi, Veera Raghavan, et al.
Publicado: (2021)

Does COVID-19 infection significantly affect liver transplantation? Results of liver transplantation in the COVID-19 era at a single, high-volume centre
por: Moradi, Alimohammad, et al.
Publicado: (2023)

Effect of COVID-19 on presentations of decompensated liver disease in Scotland
por: Manship, Thomas, et al.
Publicado: (2022)

Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis
por: Salhab, Ahmad, et al.
Publicado: (2022)

The societal burden of chronic liver diseases: results from the COME study
por: Scalone, Luciana, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r6smqperqjs73dcd2fcg0bma78